55513-0206
MVASI
Bevacizumab-awwb
INJECTION, SOLUTION
Intravenous
BEVACIZUMAB
100.0
mg/4mL

BEVACIZUMAB
100.0
mg/4mL
55513-0206-01
1 VIAL in 1 CARTON (55513-206-01) > 4 mL in 1 VIAL
June 1, 2018
Immunotherapy
Monoclonal Antibody
VEGFR
 
 
In Use